|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
on1148202079 |
| 003 |
OCoLC |
| 005 |
20240909213021.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
200405s2020 si o 000 0 eng d |
| 040 |
|
|
|a YDX
|b eng
|e pn
|c YDX
|d GW5XE
|d EBLCP
|d LQU
|d OCLCQ
|d OCLCF
|d UKAHL
|d UKMGB
|d SFB
|d OCLCO
|d ORU
|d N$T
|d OCLCA
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCL
|d OCLCO
|d OCLCL
|
| 015 |
|
|
|a GBC080678
|2 bnb
|
| 016 |
7 |
|
|a 019823096
|2 Uk
|
| 019 |
|
|
|a 1148863958
|a 1152540402
|a 1153162386
|a 1153946860
|a 1154460228
|a 1155213277
|a 1182531210
|a 1183414456
|
| 020 |
|
|
|a 9789811521959
|q (electronic bk.)
|
| 020 |
|
|
|a 9811521956
|q (electronic bk.)
|
| 020 |
|
|
|z 9811521948
|
| 020 |
|
|
|z 9789811521942
|
| 024 |
8 |
|
|a 10.1007/978-981-15-2
|
| 035 |
|
|
|a (OCoLC)1148202079
|z (OCoLC)1148863958
|z (OCoLC)1152540402
|z (OCoLC)1153162386
|z (OCoLC)1153946860
|z (OCoLC)1154460228
|z (OCoLC)1155213277
|z (OCoLC)1182531210
|z (OCoLC)1183414456
|
| 037 |
|
|
|a com.springer.onix.9789811521959
|b Springer Nature
|
| 050 |
|
4 |
|a RS380
|
| 049 |
|
|
|a HCDD
|
| 245 |
0 |
0 |
|a Advances in pharmaceutical biotechnology :
|b recent progress and future applications /
|c Jayanta Kumar Patra, Amritesh C. Shukla, Gitishree Das, editors.
|
| 260 |
|
|
|a Singapore :
|b Springer,
|c 2020.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Intro -- Preface -- Contents -- Contributors -- About the Editors -- Part I: Traditional and Ethnomedicine -- Chapter 1: Traditional Folk Medicine and Drug Discovery: Prospects and Outcome -- Introduction -- History of Traditional Medicine System -- Traditional Medicine System of India -- The Necessity of Traditional Folk Medicine -- Historically Important Natural Products -- Challenges in Drug Development -- Prospects and Outcome -- Conclusion -- References -- Chapter 2: Ethnomedicine for Drug Discovery -- Introduction -- Traditional Healing Practices -- Ayurveda
|
| 505 |
8 |
|
|a Traditional Korean Medicine -- Traditional Chinese Medicine (TCM) -- Iranian Traditional Medicine (ITM) -- African Traditional Medicine (ATM) -- Ancient Greek Medicine -- Drug Discovery -- Jasmonates -- Salicylic Acid (SA) -- Artemisinin -- Paclitaxel -- Conclusions -- References -- Chapter 3: Medicinal and Aromatic Plants: Store House to Herbal Antimicrobials -- Introduction -- Abstraction and Deployment of Aroma Principles -- Distillation -- Absolute Flower Oils -- Enfleurage -- Physical-Chemical Properties of Essential Oils -- Storage of Essential Oils -- Mother Medicine of Nature -- Tulsi Mata
|
| 505 |
8 |
|
|a Ocimum sanctum (L.) (Lamiaceae) -- Conclusion -- References -- Chapter 4: Ethnomedicinal Plants of North-East India as a Potential Target for Drug Discovery Against Type 2 Diabetes Mellitus -- Introduction -- Diabetes and Its Burden in India -- Ethnomedicinal Plants of North-east India Utilized for the Management of Type 2 Diabetes -- Aegle marmelos -- Amomum linguiforme -- Annona squamosa -- Azadirachta indica -- Cajanus cajan -- Cinnamomum impressinervium -- Colocasia esculenta -- Coriandrum sativum -- Dillenia indica -- Enhydra fluctuans -- Bombax ceiba -- Erythrina stricta -- Piper griffithii
|
| 505 |
8 |
|
|a Zingiber officinale -- Euphorbia ligularia -- Ficus hispida -- Garcinia pedunculata -- Justicia adhatoda -- Kalanchoe pinnata -- Litsea glutinosa -- Solanum indicum -- Sterculia villosa -- Syzygium cumini -- Tabernaemontana divaricata -- Tinospora cordifolia -- Plumeria acuminata -- Sesamum orientale -- Nigella sativa -- Conclusion -- References -- Chapter 5: Application of Phytochemicals in Pharmaceuticals -- Introduction -- Classification and Health Benefits of Phytoconstituents -- Group I: Terpenoids or Terpenes -- Group I (A): Tocopherols and Tocotrienols -- Group I (B): Carotenoid Terpenes
|
| 505 |
8 |
|
|a Group I (C): Limonoids Group -- Group I (D): Phytosterol Group -- Group II: Polyphenolic Compounds -- Group II (A): Phenolic Components -- Group II (B): Flavonoidal Components -- Group II (C): Catechins and Gallic Acids -- Group II (D): Isoflavonoids -- Group II (E): Anthocyanidins -- Group III: Alkaloids and Other Nitrogen-Containing Metabolites -- Group III (A): Glucosinolates -- Group III (B): Indole Alkaloids -- Group IV: Dietary Fiber -- Regulatory Aspects of Phytochemicals as Nutraceuticals -- Future Prospects of Phytochemicals in Pharmaceuticals -- Conclusions -- References
|
| 520 |
|
|
|a This book explains both the basic science and the applications of biotechnology-derived pharmaceuticals, with special emphasis on their clinical uses. The foundations of pharmaceutical biotechnology lie mainly in the capability of plants, microorganism, and animals to produce low and high molecular weight compounds useful as therapeutics. Pharmaceutical biotechnology has flourished since the advent of recombinant DNA technology and metabolic engineering, supported by the well-developed bioprocess technology. A large number of monoclonal antibodies and therapeutic proteins have been approved, delivering meaningful contributions to patients lives, and the techniques of biotechnology are also a driving force in modern drug discovery. Due to this rapid growth in the importance of biopharmaceuticals and the techniques of biotechnologies to modern medicine and the life sciences, the field of pharmaceutical biotechnology has become an increasingly important component in the education of pharmacists and pharmaceutical scientists. This book will serve as a complete one-stop source on the subject for undergraduate and graduate pharmacists, pharmaceutical science students, and pharmaceutical scientists in industry and academia.
|
| 650 |
|
0 |
|a Pharmaceutical biotechnology.
|
| 650 |
|
0 |
|a Biotechnology.
|
| 650 |
|
0 |
|a Bioengineering.
|
| 650 |
|
0 |
|a Phytonutrients.
|
| 650 |
|
0 |
|a Biopharmaceutics.
|
| 650 |
|
7 |
|a bioengineering.
|2 aat
|
| 650 |
|
7 |
|a Phytonutrients
|2 fast
|
| 650 |
|
7 |
|a Biotechnology
|2 fast
|
| 650 |
|
7 |
|a Biopharmaceutics
|2 fast
|
| 650 |
|
7 |
|a Bioengineering
|2 fast
|
| 650 |
|
7 |
|a Pharmaceutical biotechnology
|2 fast
|
| 650 |
|
7 |
|a Biotecnologia farmacèutica.
|2 thub
|
| 650 |
|
7 |
|a Quimioteràpia.
|2 thub
|
| 655 |
|
7 |
|a Llibres electrònics.
|2 thub
|
| 700 |
1 |
|
|a Patra, Jayanta Kumar.
|
| 700 |
1 |
|
|a Shukla, Amritesh C.
|
| 700 |
1 |
|
|a Das, Gitishree.
|
| 758 |
|
|
|i has work:
|a Advances in pharmaceutical biotechnology (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCGBx6BCFp997crrTX6vdV3
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|t Advances in pharmaceutical biotechnology.
|d Singapore : Springer, 2020
|z 9811521948
|z 9789811521942
|w (OCoLC)1127924511
|
| 856 |
4 |
0 |
|u https://holycross.idm.oclc.org/login?auth=cas&url=https://link.springer.com/10.1007/978-981-15-2195-9
|y Click for online access
|
| 903 |
|
|
|a SPRING-BIOMED2020
|
| 994 |
|
|
|a 92
|b HCD
|